Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Interhospital Transport of Critically Ill Children to PICUs in the United Kingdom and Republic of Ireland: Analysis of an International Dataset.

Ramnarayan P, Dimitriades K, Freeburn L, Kashyap A, Dixon M, Barry PW, Claydon-Smith K, Wardhaugh A, Lamming CR, Draper ES; United Kingdom Paediatric Intensive Care Society Acute Transport Group.

Pediatr Crit Care Med. 2018 Jun;19(6):e300-e311. doi: 10.1097/PCC.0000000000001506.

PMID:
29432405
2.

Development of an Intelligent Spacer Data Logger System.

O'Callaghan C, Smith NJ, Barry PW, Denyer J.

J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):444-450. doi: 10.1089/jamp.2017.1375. Epub 2017 Aug 28.

PMID:
28846487
3.

Inpatient management of diabetic foot problems: summary of NICE guidance.

Tan T, Shaw EJ, Siddiqui F, Kandaswamy P, Barry PW, Baker M; Guideline Development Group.

BMJ. 2011 Mar 23;342:d1280. doi: 10.1136/bmj.d1280. No abstract available.

PMID:
21430002
4.

Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance.

Sackeyfio A, Senthinathan A, Kandaswamy P, Barry PW, Shaw B, Baker M; Guideline Development Group.

BMJ. 2011 Feb 23;342:d747. doi: 10.1136/bmj.d747. No abstract available.

PMID:
21345912
5.

Nebulisation of corticosteroid suspensions and solutions with a beta(2) agonist.

O'Callaghan CL, White JA, Jackson JM, Barry PW, Kantar A.

J Pharm Pharmacol. 2008 May;60(5):601-5. doi: 10.1211/jpp.60.5.0005.

PMID:
18416936
6.

Altitude-related cough.

Mason NP, Barry PW.

Pulm Pharmacol Ther. 2007;20(4):388-95. Epub 2006 Nov 16. Review.

PMID:
17196414
7.

Enhanced delivery of nebulised salbutamol during non-invasive ventilation.

Calvert LD, Jackson JM, White JA, Barry PW, Kinnear WJ, O'Callaghan C.

J Pharm Pharmacol. 2006 Nov;58(11):1553-7.

PMID:
17132219
8.

Delivery of nebulized budesonide is affected by nebulizer type and breathing pattern.

O'Callaghan C, White J, Jackson J, Barry PW, Kantar A.

J Pharm Pharmacol. 2005 Jun;57(6):787-90.

PMID:
15969935
9.

Effect of device inhalational resistance on the three-dimensional configuration of the upper airway.

Ehtezazi T, Horsfield MA, Barry PW, Goodenough P, O'callaghan C.

J Pharm Sci. 2005 Jul;94(7):1418-26.

PMID:
15920765
10.

Dynamic change of the upper airway during inhalation via aerosol delivery devices.

Ehtezazi T, Horsfield MA, Barry PW, O'Callaghan C.

J Aerosol Med. 2004 Winter;17(4):325-34.

PMID:
15684732
11.

A randomised crossover trial of facemask efficacy.

Hayden JT, Smith N, Woolf DA, Barry PW, O'Callaghan C.

Arch Dis Child. 2004 Jan;89(1):72-3.

12.

The influence of inhaler selection on efficacy of asthma therapies.

Barry PW, O'Callaghan C.

Adv Drug Deliv Rev. 2003 Jul 18;55(7):879-923. Review.

PMID:
12842606
13.

Altitude illness.

Barry PW, Pollard AJ.

BMJ. 2003 Apr 26;326(7395):915-9. Review. No abstract available.

14.

The future of nebulization.

Barry PW.

Respir Care. 2002 Dec;47(12):1459-69; discussion 1469-70.

PMID:
12467503
15.

Increased resting bronchial tone in normal subjects acclimatised to altitude.

Wilson CM, Bakewell SE, Miller MR, Hart ND, McMorrow RC, Barry PW, Collier DJ, Watt SJ, Pollard AJ.

Thorax. 2002 May;57(5):400-4.

16.

Nasal peak inspiratory flow at altitude.

Barry PW, Mason NP, Richalet JP.

Eur Respir J. 2002 Jan;19(1):16-9.

17.

Serial changes in spirometry during an ascent to 5,300 m in the Nepalese Himalayas.

Mason NP, Barry PW, Pollard AJ, Collier DJ, Taub NA, Miller MR, Milledge JS.

High Alt Med Biol. 2000 Fall;1(3):185-95.

PMID:
11254228
18.

Asthma drug delivery devices for children.

O'Callaghan C, Barry PW.

BMJ. 2000 Mar 11;320(7236):664. No abstract available.

19.

How to choose delivery devices for asthma.

O'Callaghan C, Barry PW.

Arch Dis Child. 2000 Mar;82(3):185-7. No abstract available.

20.

Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.

Barry PW.

Anaesth Intensive Care. 1999 Dec;27(6):670-1. No abstract available.

21.

The output of budesonide from spacer devices assessed under simulated breathing conditions.

Barry PW, O'Callaghan C.

J Allergy Clin Immunol. 1999 Dec;104(6):1205-10.

PMID:
10589002
22.

An in vitro analysis of the output of budesonide from different nebulizers.

Barry PW, O'Callaghan C.

J Allergy Clin Immunol. 1999 Dec;104(6):1168-73.

PMID:
10588997
23.

New formulation metered dose inhaler increases breath alcohol levels.

Barry PW, O'Callaghan C.

Respir Med. 1999 Mar;93(3):167-8.

24.

An in vitro analysis of the output of salbutamol from different nebulizers.

Barry PW, O'Callaghan C.

Eur Respir J. 1999 May;13(5):1164-9.

26.

Cough frequency and cough receptor sensitivity to citric acid challenge during a simulated ascent to extreme altitude.

Mason NP, Barry PW, Despiau G, Gardette B, Richalet JP.

Eur Respir J. 1999 Mar;13(3):508-13.

27.

Drug output from nebulizers is dependent on the method of measurement.

Barry PW, O'Callaghan C.

Eur Respir J. 1998 Aug;12(2):463-6.

28.

The output of budesonide from nebulizers.

Barry PW, O'Callaghan C.

J Allergy Clin Immunol. 1998 Aug;102(2):321-2. No abstract available.

PMID:
9723679
29.

Cough frequency and cough-receptor sensitivity are increased in man at altitude.

Barry PW, Mason NP, Riordan M, O'Callaghan C.

Clin Sci (Lond). 1997 Aug;93(2):181-6.

PMID:
9301434
30.

Hypoxia, hypocapnia and spirometry at altitude.

Pollard AJ, Barry PW, Mason NP, Collier DJ, Pollard RC, Pollard PF, Martin I, Fraser RS, Miller MR, Milledge JS.

Clin Sci (Lond). 1997 Jun;92(6):593-8. Erratum in: Clin Sci (Colch) 1997 Dec;93(6):611.

PMID:
9205420
32.

Nebuliser therapy in childhood.

Barry PW, O'Callaghan C.

Thorax. 1997 Apr;52 Suppl 2:S78-88. Review. No abstract available.

33.

The science of nebulised drug delivery.

O'Callaghan C, Barry PW.

Thorax. 1997 Apr;52 Suppl 2:S31-44. Review. No abstract available.

34.

Nasal mucociliary transport is impaired at altitude.

Barry PW, Mason NP, O'Callaghan C.

Eur Respir J. 1997 Jan;10(1):35-7.

35.

Inhalational drug delivery from seven different spacer devices.

Barry PW, O'Callaghan C.

Thorax. 1996 Aug;51(8):835-40.

36.

Effect of altitude on spirometric parameters and the performance of peak flow meters.

Pollard AJ, Mason NP, Barry PW, Pollard RC, Collier DJ, Fraser RS, Miller MR, Milledge JS.

Thorax. 1996 Feb;51(2):175-8.

38.

Emergency treatment of asthma.

Barry PW, O'Callaghan C.

Thorax. 1995 Jul;50(7):814. No abstract available.

39.

Sampling for analysing blood gas pressures. Mount Everest study supports use of capillary samples.

Barry PW, Mason NP, Collier D.

BMJ. 1995 Apr 22;310(6986):1072. No abstract available.

40.

Brain and respiratory cilia: the effect of temperature.

O'Callaghan C, Achaval M, Forsythe I, Barry PW.

Biol Neonate. 1995;68(6):394-7.

PMID:
8721882
42.
43.

Paediatric use of intensive care.

Barry PW, Hocking MD.

Arch Dis Child. 1994 May;70(5):391-4.

44.

Optimum use of a spacer device.

Barry PW, Robertson CF, O'Callaghan C.

Arch Dis Child. 1993 Dec;69(6):693-4.

45.

Infant rib fracture--birth trauma or non-accidental injury.

Barry PW, Hocking MD.

Arch Dis Child. 1993 Feb;68(2):250. No abstract available.

Supplemental Content

Loading ...
Support Center